EZH2 and non-small cell lung carcinoma: Sun et al. [14] showed that LINC00511 can bind to the histone methyltransferase enhancer of zeste homolog 2 (EZH2) and then suppress the expression of p57 to promote the initiation and development of non-small-cell lung cancer.